Date Filed | Type | Description |
08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/18/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 10,353 shares
@ $0 Granted 6,335 shares
@ $0 |
|
08/15/2023 |
4
| Bastone Bronwen (Chief People Officer) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 117 shares
@ $0 Sold 41 shares
@ $7.89, valued at
$323.5 |
|
08/15/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 4,045 shares
@ $0 Sold 1,760 shares
@ $7.89, valued at
$13.9k
|
|
08/15/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 1,332 shares
@ $0 |
|
08/14/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 1,466 shares
@ $0 |
|
08/14/2023 |
4
| Bastone Bronwen (Chief People Officer) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 130 shares
@ $0 Sold 44 shares
@ $8.1, valued at
$356.4 |
|
08/14/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 4,451 shares
@ $0 Sold 1,850 shares
@ $8.1, valued at
$15k
|
|
08/11/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 1,599 shares
@ $0 |
|
08/11/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 4,855 shares
@ $0 Sold 2,106 shares
@ $8.08, valued at
$17k
|
|
08/11/2023 |
4
| Bastone Bronwen (Chief People Officer) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 141 shares
@ $0 Sold 50 shares
@ $8.08, valued at
$404 |
|
08/10/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 5,259 shares
@ $0 Sold 2,317 shares
@ $8.32, valued at
$19.3k
|
|
08/10/2023 |
4
| Bastone Bronwen (Chief People Officer) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 153 shares
@ $0 Sold 55 shares
@ $8.32, valued at
$457.6 |
|
08/10/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 1,733 shares
@ $0 |
|
08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/13/2023 |
4
| Hammoud Tarek (10% Owner) has filed a Form 4 on Enfusion, Inc.
Txns:
| Sold 1,000,000 shares
@ $10.7, valued at
$10.7M
|
|
06/28/2023 |
4
| Somers Deirdre (Director) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 15,233 shares
@ $0 |
|
06/28/2023 |
4
| Spellacy Michael (Director) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 15,233 shares
@ $0 |
|
06/28/2023 |
4
| Hauser Jan (Director) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 15,233 shares
@ $0 |
|
06/28/2023 |
4
| DeRose Kathleen (Director) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 15,233 shares
@ $0 |
|
06/28/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 15,233 shares
@ $0 |
|
06/16/2023 |
4
| Bernstein Bradford E (10% Owner) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 1,142,857 shares
@ $8.1195, valued at
$9.3M
|
|
06/16/2023 |
3
| FTV Investment Holdings, L.P. (10% Owner) has filed a Form 3 on Enfusion, Inc. |
05/26/2023 |
4
| Bastone Bronwen (Chief People Officer) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 3,298 shares
@ $0 Paid exercise price by delivering 1,112 shares
@ $7.93, valued at
$8.8k
|
|
05/26/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 37,396 shares
@ $0 |
|
05/26/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.
Txns:
| Granted 113,538 shares
@ $0 Paid exercise price by delivering 47,630 shares
@ $7.93, valued at
$377.7k
|
|
05/24/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.
Txns:
| Sold 3,877 shares
@ $8, valued at
$31k
Sold 50,000 shares
@ $7.91, valued at
$395.5k
|
|
05/12/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.
Txns:
| Sold 15,048 shares
@ $8.34, valued at
$125.5k
|
|
04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|